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Does hypernatremia impact mortality in Toxic Epidermal
Necrolysis?
Wird die Mortalität bei Toxisch Epidermaler Nekrolyse durch eine
Hypernatriämie beeinflusst?
Abstract
Introduction: In-hospital hypernatremia is associated with increased
mortality rates. We want to elucidate the impact of in-hospital acquired







Purpose: Is there an association between hypernatremia and mortality
in patients with TEN? Peter L. Stollwerck
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Method: Retrospective study of 25 patients with TEN. Laboratory elec-







1 Results: In Group A 10 patients with a TBSA of 74±25% (mean ±
standarddeviation),andaSCORTEN-Scoreof2.7±0.9weresummarized.
Diuresiswithinthefirst10daysafteradmissionwas1±0.3ml/kg/hour.
1 Department of Plastic and
Hand Surgery, Burn Unit, In Group B 15 patients with a TBSA of 76±19%, and a SCORTEN-Score
of3.5±1wereincluded.Diuresiswithinthefirst10daysafteradmission UniversityHospitalSchleswig-
was1.4±0.4ml/kg/hour.Hypernatremiaoccurredonday3.3±2.4after Holstein Campus Lübeck,
Germany admission and persisted for 5.3±2.9 days. Statistical analysis showed
a significantly higher diuresis (p=0.007) and SCORTEN-Score (p=0.04)
inthehypernatremicpatients.Onenormonatremicand8hypernatremic
patientsdiedduringICU-stay(overallmortalityrate36%).Asignificantly
higher mortality rate was found in Group B (odds ratio: 13,5; 95% con-
fidence interval: 1.34–135.98; p=0.01) during ICU-stay.
Conclusion: TEN patients with an in-hospital acquired hypernatremia
have an increased mortality risk. Close electrolyte monitoring is advis-
able in these patients.
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Zusammenfassung
Einleitung: Hypernatriämien gehen bei schwerstkranken Patienten mit
einer erhöhten Mortalität einher. Die kausalen Zusammenhänge sind
noch weitgehend unklar. Ziel dieser Studie war es festzustellen, ob hy-
pernatriäme Patienten mit einer Toxisch Epidermalen Nekrolyse (TEN)
eine erhöhte Mortalität aufweisen.
Material und Methoden: Retrospektive Studie an 25 TEN-Patienten. Es
erfolgte die Differenzierung in normonatriäm (Gruppe A) und hyperna-
triäm(GruppeB).NebendemSerum-Natrium-Verlaufwurdendietägliche
Diuresemenge und die Mortalitätsrate analysiert.
Ergebnisse: In Gruppe A konnten 10 Patienten mit einer Epidermolyse
von 74±25% der Köperoberfläche (KOF) und einem SCORTEN von
2,7±0,9 eingeschlossen werden. Die Diurese innerhalb der ersten 10
Tage betrug 1±0,3 ml/kg/Stunde. In Gruppe B wurden 15 Patienten
mit einer Epidermolyse von 76±19% der KOF und einem SCORTEN von
3,5±1 eingeschlossen. Die durchschnittliche Diurese innerhalb der
ersten 10 Tage betrug 1,4±0,4 ml/kg/Stunde. Eine Hypernatriämie
wurde am 3. ±2 Tage nach der stationären Einweisung manifest und
persistiertefür5±3Tage.DiestatistischeAnalyseergabeinesignifikant
höhere Diurese (p=0,007) und SCORTEN (p=0,04) in Gruppe B. Ein
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Research Article OPEN ACCESSnormonatriämer and 8 hypernatriäme Patienten verstarben auf der In-
tensivstation. In Gruppe B wurde eine signifikant höhere Mortalität be-
rechnet (Odds Ratio: 13,5; 95% Konfidenz-Intervall: 1,34–135,98; p
0,01).
Schlussfolgerung: Hypernatriäme Patienten, welche an einer TEN er-
krankt sind, haben ein erhöhtes Mortalitätsrisiko. Eine engmaschige
Kontrolle der Elektrolyte erscheint daher empfehlenswert.
Schlüsselwörter: Toxisch Epidermale Nekrolyse, Hypernatriämie,
Intensivmedizin
Introduction
Toxic Epidermal Necrolysis (TEN) is a rare disease with
an incidence of approximately 1–2 per million/year [1],
[2]. Prodromi are unspecific symptoms like fever and
malaise. TEN is clinically diagnosed by cutaneous ery-
thema,progressiveblistering,epidermolysis(>30%Total
Body Surface Area (TBSA)), mucosal erosions, and/or
ophthalmic affection. The cutaneous eruption is charac-
terizedbytheNikolskysign,whichisdefinedasepiderm-
olysiswithmobilityoftheaffectedepidermisuponhealthy
skin and epidermal detachment on the slightest friction
[3].Skinbiopsyistheonlyreliablemethodtoconfirmthe
diagnosis of TEN (separation of the epidermo-dermal
junction) in correlation with the macroscopic clinical
presentation of the skin [4]. Burn center treatment is
recommended in TEN-patients, because of the extensive
cutaneous defects [5].
High mortality rates of TEN have been reported (14 to
70%) [6], [7], [8], [9]. The independent predictors of
mortality in TEN are Age (>40 years), heart rate
(>120/min), presence of malignant tumors, initial epi-
dermolysis (>10% affected surface area), serum urea
(>10 mmol/l), serum bicarbonate (<20 mmol/l), and
serum glucose (>14 mmol/l). These variables are de-
scribed by Bastuji-Garin et al. after evaluating epidemi-
ologic and diagnostic parameters [10].
Hypernatremia (>145 mmol/) is a common electrolyte
disorder characterized by a deficit of total-body water
relative to total-body sodium [11]. Hypernatremia can
result from water loss, or hypertonic sodium gain. It is
almostneverfoundinanalertpatientwithanormalthirst
mechanism and access to water. The two main defense
mechanismsagainsthypernatremiaarethirstandstimu-
lationofvasopressinrelease[12].Hypernatremiacanbe
classifiedaccording to thepatient's volume status(hypo-
volemia,euvolemia,hypervolemia).Inhypovolemichyper-
natremia free water loss exceeds sodium loss, whereas
patients with an euvolemic hypernatremic state have
purewaterlosswithoutsignsofhypovolemia.Hypervolem-
ic hypernatremia, caused by a pure sodium overload is
rare and frequently caused iatrogenically, by excessive
sodium administration, overcorrection of hyponatremia,
hypertonicdialysate,andhypertonicenteralorparenteral
hyperalimentation. Noniatrogenic etiologies include vari-
ousmineralocorticoiddeficiencies,saltwaterneardrown-
ings,ingestionofimproperlypreparedinfantformula,and
ingestion of salt tablets. Free water loss can result from
extrarenal (i.e. sweating, burns, diarrhea, skin diseases)
orrenal(diuretics,severeosmoticdiuresis,severeglucos-
uriaindiabetics,orelevatedureainpostobstructivediur-
esis) causes [12]. It is difficult to distinguish whether
these high mortality rates are caused by the hyper-
natremia itself, the underlying disease process, or the
sequelae of hypernatremia treatment [13].
Innon-TENcriticallyillpatientsanacquiredhypernatremic
state appears to be associated with increased mortality
rates(rangefrom31%to66%)[13],[14],[15],[16],[17],
[18], [19]. We present a retrospective study to elucidate
the impact of in-hospital acquired hypernatremia on
mortality.
Materials and methods
Fifty-two patients with a severe cutaneous drug reaction
were treated during the past 10 years. Twenty-five pa-
tientswithTEN(epidermolysis>30%TBSA)wereidentified
retrospectively. Patients with an epidermolysis <30%
TBSAwereexcludedfromthisstudy,becauseofthelower
severity of illness and to provide a better comparability
in with previous studies in the TEN group. Hemodynamic
monitoring was realized by continuous invasive blood
pressuremeasurement.Toachieveabalancedfluidregi-
men, urinary output, mean arterial blood pressure, and
blood gas analysis were performed every 1–3 hours.
Transdermal water loss (epidermolytic skin) was calcu-
lated with 40 ml/%-TBSA/day. Amount and type of infus-
ate (Ringer's solution, glucose 5%) and/or diuretics (e.g.
Furosemid) were adjusted to individual requirements.
Hypernatremiawasdefinedatserumsodiumlevels≥146
mmol/l. Hypernatremia was treated immediately with an
increased infusion rate of electrolyte free water (glucose
5%).
Statistics were performed with SPSS
® 15.0 (SPSS Inc.,
Chicago, USA). To estimate significance Mann-Whitney-
U-orCHI-square-testwereperformed.Resultsarewritten
in mean value ± standard deviation. Survival was calcu-
lated using Kaplan-Meier method; logrank (Mantel-Cox)
analysis was used to calculate statistical significance.
Results
25 (17 female; 8 male) patients with a mean age of
59±18years,ameanepidermolysissurfaceof76.4±19%,
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Namdar et al.: Does hypernatremia impact mortality in Toxic Epidermal ...Table1:PatientscharacteristicsdividedinGroupA(withouthypernatremia)andGroupB(withhypernatremia).10-days-diuresis
[ml/kg/hours], serum sodium level on admission [mmol/l], age [years], TBSA [%], SCORTEN-Score, mean amount of daily
administered furorese [mg/day], mean daily infusion-diuresis-ratio (IDR) [ml] for two periods (day 1 to 4 and day 1 to 10) of
each subgroup is displayed with values for mean, standard deviation (SD), minimum, maximum and p-value.
Figure 1: Survival curves according to the TEN patients with an in-hospital acquired hypernatremic state. The probability of
hospital mortality over time was determined using Kaplan-Meier survival analysis. Logrank (Mantel-Cox) analysis evidenced a
significant difference between Group A (normonatremic) and Group B (hypernatremic) curves.
and a mean SCORTEN-Score of 3.2±1 were included.
Meanurinaryoutputwas1.2±0.4ml/hourwithinthefirst
10 days after admission. Patients were separated into
two groups: Group A (without) and Group B (with) in-hos-
pital acquired hypernatremia.
In Group A, 10 patients (5 female; 5 male) were summar-
ized.Meanage,affectedTBSA,SCORTEN,diuresis,serum
sodiumlevel(onadmission),amountoffuroreseanddaily
infusion-diuresis-ratio (IDR) (for day 1 to 4 and day 1 to
10)aregiveninTable1.Fourpatientsshowedamucosal
involvement. Mean creatinine (10 days after admission)
was65±27µmol/l.Sixpatients(60%)didnotreceiveany
diureticmedication.Therewasnoelevatedserumsodium
level in Group A within the first 10 days after admission.
InGroupB15patients(12female;3male)wereincluded.
Mean age, affected TBSA, SCORTEN, diuresis, serum so-
dium level (on admission), amount of furorese and daily
IDR (for day 1 to 4 and day 1 to 10) are given in Table 1.
Five patients showed a mucosal involvement. Mean cre-
atinine (10 days after admission) was 93±49 µmol/l.
Four patients (27%) did not receive any diuretic medica-
tion.Hypernatremiaoccurredonday3.3±2.4afteradmis-
sion and persisted for 5.3±2.9 days.
No significant differences in age, sex, affected TBSA,
mucosal involvement and daily amount of furorese ap-
plied (over a 10-days-period) and daily IDR were found
betweenGroupAandGroupB.Statisticalanalysisshowed
asignificantlyhighermeancreatininewithin10daysafter
admission (p=0.025), higher diuresis (p=0.007), higher
meanserumsodiumlevelsonadmission(p=0.004),and
a higher SCORTEN-Score (p=0.04) in Group B (Table 1).
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during ICU-stay (overall mortality 36%). A significantly
higher mortality rate was found in Group B (odds ratio:
13,5; 95% confidence interval: 1.34–135.98; p=0.01)
duringICU-stay(Figure1).4patientsdiedinasepticstate
duetopneumonia,2patientsdiedaftermyocardialinfarc-
tion, and 1 patient died due to a pulmonary embolism.
The remaining 2 patients died of multi-organ failure for
which no pathologic mechanism could be identified.
Discussion
TEN is a rare, but life-threatening, exfoliative dermatitis,
affecting the skin and mucous membranes. The large
open surface caused by epidermolysis, leads to an
enormous transdermal fluid loss of up to 4 liters per day
[8]. In TEN, fluid regimen cannot be performed in a
standardized way. The type and the amount of infusate
needtobeadjustedtoindividualparameterssuchasthe
extent of epidermolysis, body weight, and co-morbidities




that enables the physician to determine the severity of
theillnessandriskofdeathonadmissionofTENpatients
[10]. Age, tachycardia, presence of malignancy, initial
epidermolysis,serumurea,serumbicarbonate,andserum
glucosehavebeenshowntopredictmortalityinTEN[10].
In-hospital acquired hypernatremia is a common electro-
lyte disorder and is frequently caused iatrogenically [12],
[20], [21]. Hypernatremia (>146 mmol/l) is a reliable
markerforsystemicdehydration[16].Evenashortperiod
of hypernatremia may lead to an induction of apoptosis
apartfromitsneurologiceffects[22],[23].Serumsodium
iseasytoevaluateinanICUsettingbybloodgasanalysis
and provides additional information about the patients’
systemic fluid status [24]. Patients admitted to an ICU
have a higher incidence of hypernatremia compared to
general hospital population and there is a strong correl-
ation in peak serum sodium level and mortality [16].
In the study of Bastuji-Garin et al. [10] serum sodium
imbalance(hypo-andhypernatremia)wasshowntohave
a significant univariate association to patients’ survival.
Multivariateanalysisfailedtoproveahypernatremicstate
as an independent predictor of death. Hence, serum so-





this study. There was a significantly higher mean serum
sodium level at admission in Group B (with hyper-
natremia),butonly2individualsshowedabnormallyhigh
values(>146mmol/l).TheotherGroupBpatientsshowed
normal serum sodium levels at admission. In-hospital
acquired hypernatremia (Group B) occurred on day
3.3±2.4 after admission. The mean daily IDR for the two
analyzed periods (day 1 to 4 and day 1 to 10) was higher
in the hypernatremic subgroup, but statistical analysis
did not show any significance. We registered a mortality
rate of 36% in all analyzed TEN-patients, which is at the
lower range of prior reported studies [6], [8], [9], [25].
Only1normonatremicindividualdiedwithin60daysafter
admission.13patients(52%)developedahypernatremic
state during Burn Unit stay. We registered a significantly
higher mortality in hypernatremic patients than in nor-
monatremic patients (Figure 1). The mortality rate of
hypernatremic TEN patients (60%) was comparable to
the results of other hypernatremic non-TEN studies (31%
to 66%) [13], [14], [15], [16], [17], [18], [19].
We assume that patients with a TEN have an increased
riskofsystemicdehydration.Oneexplanationmaybethe
amount of transdermal fluid loss (epidermolysis >30%
TBSA) and the painful limitation of oral feeding and fluid
uptakeduetoerosivemucousmembranelesions.Onthe
other hand, termination of the patient's prior medication
at admission – as an elementary step in TEN treatment
– can provoke alterations in urinary output. In our study
a significantly higher diuresis was detected in patients
with hypernatremia (Group B), but no larger amount of
administered diuretics was registered. A hypernatremic
state in TEN patients is a symptom, which may provoke
severecomplicationssuchasanincreasedmortality.The
reason for increased mortality in hypernatremic patients
couldnotbeidentifiedinourstudy.Evenpreviousstudies,
focused on hypernatremia and mortality, could not elab-
orate the specific mechanisms by which hypernatremia
leads to increased mortality [13], [14], [15], [16], [17],
[18],[19],[26].TherewasasignificantlyhigherSCORTEN
at admission in Group B, which indicates an increased
severity of illness in these patients compared to nor-
monatremic patients.
We conclude that even in specialized Burn Units the in-
cidenceofhypernatremiainTENpatientsisunavoidable.
In case of a hypernatremic state early intervention is ob-
ligatory. Short interval blood gas analysis is advisable to
register water imbalances early. An arterial line offers
easy electrolyte control besides continuous blood pres-
sure monitoring as well as control of pulmonary gas ex-
changeparameters.Inalife-threateningdiseaselikeTEN
we strongly recommend this approach to optimize
hemodynamicmonitoring.EarlytransferralofTENpatients
to regional Burn Units for critical care management and
optimizedwoundcarehasbeenshowntohaveapositive
effect on survival [5].
Limitations
In this retrospective study we analyzed only a small
population of hypernatremic TEN patients. There was no
standardized protocol for fluid administration protocol
after admission. The collected values and findings only
have an empiric character and should be investigated by
prospective randomized clinical trials.
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